Subscribe to NRx Newsletter
2nd quarter financial results3PLAccelerated RecoveryACTIV-3ACTIV-3bActive3bAcute Respiratory Distress SyndromeAcute Respiratory Failureacute suicidalityAdaptive Platform Trial DesignAnnual Global Investment ConferenceAnthony S Fauci MDARDSASIBAviptadilAvitpadilBARDABig Biz ShowBig Rock PartnersbiobuzzBioConnect Virtual ConferenceBiotechbiploarBipolarBipolar DepressionBNP ParibasBoosterBreakthrough Therapy DesignationBRilifeBRILife®BTDbusiness updateCAHCardinal HealthCarrie CarrettaCEOCEO updateCFOCH HealthChaim HurvitzCheddar NewsChief Executive OfficerChief Financial OfficerClinical Trialsclinical updateClosing BellCOID-19Commercial ForumlationCompany PresentationCompassionate CareconferenceCovidCovid-19COVID-19 SurvivalCOVID-AIVCovid19Critical COVID-19CromosCytokine IL-6Cytokine StormCytokinesDal BoscoDaniel JavittData Safety Monitoring BoardDavid MeltzerDeltaDelta VariantDenk PharmadepressionDirectorDisease preventionDisease prevention & Control SummitDr YoDr. Sami SaidDr. Shmuel YitzhakiDry-powder InhalerDSMBEAPEkaterine TikaradzeEmegency Use AuthorizationEmergency UseEmergency Use Authorizationerectile dysfunctionEUAEuropean QPExpanded AccessFast TrackFDAFDA EmeFDA Emergency Use AuthorizationFDA Module 3Federal Right to Try ActFinancial ResultsFourth Quarter 2022 Financial ResultsFourth Quarter Financial ResultsFox BusinessGeorgiaGeorgia Society of PhysiciansGeorgian Ministry of HealthGILDGileadGovernment of LuxembourgH.C. WainwrightH.C. Wainwright & Co.HC WainwrightHC Wainwright Annual Global Investment ConferenceHC Wainwright Global Investment ConferenceHigh Flow NasalHoustonHouston MethodistHouston Methodist JC Walkter Jr Transplant CenterI-Spyi24 NewsICUIIBRIL-6 CytokineInhaled AviptadilInterviewIQVIQVIAIra StrassbergiSpyIsraelIsrael Institute of Biological ResearchIV ZYESAMI®J. Georges YoussefJ.P. Morgan Healthcare ConferenceJ&JJihad Georges YoussefJihad Georges Youssef MDJihad Geroges YoussefJonathan JavittJournal of Infectious Diseases and TreatmentketaminelawsuitlitigationLuxembourgLuxembourg Ministry of the EconomyMannkindMDMental HealthMental Health SupportMNKDMolnupiravirNanoPassNASDAQNation of GeorgiaNational Institutes of HealthNDA ZyesamiNeedhamNehpron PharmaceuticalsNephronNephron PharmaceuticalsNeuropsychiatryNeuroscience Innovation ForumNIAIDNIHNRXNRx BriLife COVID VaccineNRx Business UpdateNRx EarningsNRx PharmaNRx PharmaceuticalsNRX-100NRX-100/101NRX-101NRX101NRXPOffice HoursOmicronOrphan Drug DesignationPandemicPeptidesPharmacovigilancePhase 2Phase 3presentationPrivate PlacementProf Jonathan JavittProf Jonathan Javitt MD MPHPsychedelicsPsychiatric CarePsychiatryPTSDQ1 EarningsQ2 EarningsQ3 EarningsQ3 Finaincial ResultsQP AuditorQP DeclarationQuantum Leap HealthcareRelief TherapeuticsRemdesivirRespiratory Distress RatioRespiratory FailureRichard G Lugar Center for Public HealthRichard Luger CenterRIght to TryRightToTryRLF-100RLF-100_002Robert BesthofRTTSachs Neuroscience Innovation ForumSami SaidSar-CoV-2Sars-CoV-2serotoninSeth Van VoorheessettlementSever COVID-19Stephen WillardSuicidal DepressionSuicidalitySuicideTechnosphereTESICOThird Quarter 2022 Financial ResultsThird Quarter Financial ResultsTreasurerType C guidanceUCIUkraineUS Food and Drug AdministrationUSFDAVaccineVaccine TrialVaccine TrialsVasoactive Intestinal PeptideVekluryVIPVirologywebcastWorld Bipolar DayZYESAMIZYESAMI®ZYESAMI® (aviptadil)ZYESAMI™ZYESAMI™ INDZysamiZYSAMI®ZYSAMI® (aviptadil)